Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing's sarcoma

European Journal of Cancer

Volumn 42, Issue 1, 2006, Pages 91-96

  Scotlandi, Katia ^a   Perdichizzi, Stefania ^a   Bernard, Ghislaine ^b   Nicoletti, Giordano ^a,c   Nanni, Patrizia ^c   Lollini, Pier Luigi ^c   Curti, Antonio ^c   Manara, Maria Cristina ^a   Benini, Stefania ^a   Bernard, Alain ^c   Picci, Piero ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone metastases; CD99; Doxorubicin; Ewing's sarcoma; Tumourigenicity

Indexed keywords

CD99 0662 MONOCLONAL ANTIBODY; CD99 ANTIGEN; DOXORUBICIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADD ON THERAPY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EWING SARCOMA; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DOXORUBICIN; DRUG THERAPY, COMBINATION; HEMATOPOIETIC STEM CELLS; HUMANS; SARCOMA, EWING'S;

EID: 29144462140     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.09.015     Document Type: Article

References (17)

1. M. Campanacci Bone and soft tissue tumors 1999 Springer-Verlag Wien
2. G. Bacci, M. Mercuri, and A. Longhi Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute Eur J Cancer 38 2002 2243 2251
3. H.E. Grier, M.D. Krailo, and N.J. Tarbell Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone N Engl J Med 348 2003 694 701
4. M. Paulussen, S. Ahrens, and M. Lehnert Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study Ann Oncol 12 2001 1619 1630
5. E.A. Kolb, B.H. Kushner, and R. Gorlick Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults J Clin Oncol 21 2003 3423 3430
6. C. Gelin, F. Aubrit, and A. Phalipon The E2 antigen, a 32 kDa glycoprotein involved in T cell adhesion process, is the MIC2 gene product EMBO J 8 1989 3253 3259
7. H.W. Sohn, E.Y. Choi, and S.H. Kim Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells Am J Pathol 153 1998 1937 1945
8. K. Scotlandi, N. Baldini, and V. Cerisano CD99 engagement: an effective therapeutic strategy for Ewing tumors Cancer Res 60 2000 5134 5142
9. V. Cerisano, Y. Aalto, and S. Perdichizzi Molecular mechanisms of CD99-induced caspase independent-cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and Zyxin as key intracellular mediators Oncogene 23 2004 5664 5674
10. C. Gelin, M.-T. Zilber, and D. Jovanovich The E2/MIC2 molecule is defined by cluster of differentiation CD99 S.F. Schlossman L. Boumsell W. Gilks Leucocyte typing V. White cell differentiation antigens Proceedings of the fifth international workshop and conference 1995 Oxford University Press Oxford 283 285
11. T.-C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
12. M.N. Dworzak, G. Fritsch, and P. Buchinger Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood Blood 83 1994 415 425
13. C. Fouchet, and P. Gane A study of coregulation and tissue specificity of XG and MIC2 gene expression in eukaryotic cells Blood 95 2000 18919 18926
14. G. Bernard, J.-P. Breittmayer, and M. de Matteis Apoptosis of immature thymocytes mediated by E2/CD99 J Immunol 158 1997 2543 2550
15. I. Alberti, G. Bernard, and A.K. Rouquette-Jazdanian CD99 isoforms expression dictates T cell functional outcomes FASEB J 16 2002 1946 1948
16. A.R. Schenkel, Z. Mamdouh, and X. Chen CD99 plays a major role in the migration of monocytes through endothelial junctions Nat Immunol 3 2002 143 150
17. G. Bernard, V. Raimondi, and I. Alberti CD99 (E2) upregulates α4β1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions Eur J Immunol 30 2000 3061 3065